BTMD
Biote Corp -A
NASDAQ · Pharmaceuticals
$2.23
+0.11 (+5.19%)
Open$2.13
Previous Close$2.12
Day High$2.29
Day Low$2.13
52W High$15.58
52W Low$11.92
Volume—
Avg Volume333.7K
Market Cap101.83M
P/E Ratio24.62
EPS$0.56
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+649.3% upside
Current
$2.23
$2.23
Target
$16.71
$16.71
$12.81
$16.71 avg
$20.08
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 23.18M | 22.38M | 21.94M |
| Net Income | 4.12M | 3.27M | 4.37M |
| Profit Margin | 17.8% | 14.6% | 19.9% |
| EBITDA | 6.14M | 5.70M | 5.36M |
| Free Cash Flow | 3.06M | 2.62M | 2.18M |
| Rev Growth | -0.5% | -5.1% | +24.1% |
| Debt/Equity | 0.22 | 0.18 | 0.21 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |